Akèy › Skleroz Amiotrofik Lateral › Arizona
Etid klinik pou Skleroz Amiotrofik Lateral nan Arizona
10 etid pou Skleroz Amiotrofik Lateral ap chèche patisipan nan sit nan Arizona.
Vil nan Arizona
Tèks ofisyèl etid la (Anglè)
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Barrow Neurological Institute, Phoenix
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07322003RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Arizona, Tucson
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
- St Joseph's Hospital and medical Center - Barrow Neurological Institute, Phoenix
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07287397ASSESS ALL ALS Study
- Barrow Neurological Institute, Phoenix
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06578195PREVENT ALL ALS Study
- Barrow Neurological Institute, Phoenix
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06581861Study of COYA 302 for the Treatment of ALS
- Barrow Neurological Institute, Phoenix
Ap rekriteFaz 2/3
Laj 18 a 80 · Tout sèks · Mizajou Aug 6, 2026 · NCT07161999PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
- Honor Health Neurology - Bob Bove Neuroscience Institute, Scottsdale
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 23, 2026 · NCT07142291EIM Via the Myolex mScan as an ALS Biomarker
- Barrow Neurological Institute, Phoenix
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT06491732Precise Robotically IMplanted Brain-Computer InterfacE
- Barrow Neurological Institute, Phoenix
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Jan 9, 2026 · NCT06429735Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
- Barrow Neurological Institute, Phoenix
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05137665Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.